berberine has been researched along with Cardiomyopathies, Primary in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac fibrosis is a crucial aspect of cardiac remodeling that can severely affect cardiac function." | 5.51 | Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats. ( Che, Y; Jin, YG; Shen, DF; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y, 2019) |
| " We hypothesized that CPU86017, derived from berberine, which possesses multi-channel blocking activity, could suppress inflammatory factors, resulting in inhibition of over-expression of ether-a-go-go (ERG) and an augmented incidence of ventricular fibrillation (VF) in ischaemia/reperfusion (I/R)." | 3.74 | Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent. ( Dai, DZ; Dai, Y; Du, RH; Tang, WH; Yi, HW, 2008) |
| "Cardiac fibrosis is a crucial aspect of cardiac remodeling that can severely affect cardiac function." | 1.51 | Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats. ( Che, Y; Jin, YG; Shen, DF; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 1 |
| Tang, XQ | 1 |
| Shi, Y | 1 |
| Li, HM | 1 |
| Meng, ZY | 1 |
| Chen, H | 1 |
| Li, XH | 1 |
| Chen, YC | 1 |
| Liu, H | 1 |
| Hong, Y | 1 |
| Xu, HH | 1 |
| Liu, L | 1 |
| Zhao, L | 1 |
| Han, WN | 1 |
| Liu, X | 1 |
| Zhang, Y | 2 |
| Che, Y | 1 |
| Shen, DF | 1 |
| Wang, ZP | 1 |
| Jin, YG | 1 |
| Wu, QQ | 1 |
| Wang, SS | 1 |
| Yuan, Y | 1 |
| Hao, G | 1 |
| Yu, Y | 1 |
| Gu, B | 1 |
| Xing, Y | 1 |
| Xue, M | 1 |
| Du, RH | 1 |
| Yi, HW | 1 |
| Dai, DZ | 2 |
| Tang, WH | 1 |
| Dai, Y | 2 |
| Na, T | 1 |
| Huang, ZJ | 1 |
5 other studies available for berberine and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy.
Topics: Aging; Animals; Berberine; Cardiomyopathies; Mice; Mitophagy; Signal Transduction | 2023 |
Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats.
Topics: Animals; Berberine; Cardiomyopathies; Cell Transdifferentiation; Cells, Cultured; Coculture Techniqu | 2019 |
Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin.
Topics: Animals; Berberine; Cardiomyopathies; Cardiotoxins; Doxorubicin; Male; Rats; Rats, Sprague-Dawley | 2015 |
Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptidases; Berberine; Cardiomegaly | 2008 |
Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.
Topics: Animals; Anti-Arrhythmia Agents; Aspartic Acid Endopeptidases; Berberine; Calcium; Cardiomyopathies; | 2007 |